Barely Significant
← all excerpts

A novel palmitoylation-based molecular signature reveals COX6A1 as a key regulator in metabolic dysfunction-associated steatotic liver disease.

J Transl Med · 2025 · PMC12581582 · PMID 41185013

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantp < 0.001actually significant
Specifically, genes such as PNPLA4, DGAT2, MGLL, LIPE, ATP8B1, CETP, PNPLA3, LIPG, LIPA, CPT1A, APOE, CD36, CPT2, ACOX1, MOGAT2, PLIN4, LPL, PNPLA2, and DGAT1 exhibited highly significant differences ( p < 0.001), while LYPLA1, SLC27A1, MPP1, PPT1, HADHB, GPAT3, MTTP, LPCAT1, and ZDHHC5 showed moderate differences ( p < 0.05) (Fig. 3 E).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.